IMCR
Immunocore Holdings Ltd
NASDAQ: IMCR · HEALTHCARE · BIOTECHNOLOGY
$27.92
-3.02% today
Updated 2026-04-29
Market cap
$1.42B
P/E ratio
—
P/S ratio
3.55x
EPS (TTM)
$-0.71
Dividend yield
—
52W range
$27 – $41
Volume
0.4M
Immunocore Holdings Ltd (IMCR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.18M | $64.18M | $-26.48M | $-45.31M | $-81.90M | $-16.63M | $-101.38M | $-60.57M | $-143.11M | $-49.21M | $2.33M | $26.06M | $-7.97M |
| Capital expenditures | $934818.00 | $3.27M | $8.56M | $7.59M | $23.52M | $3.54M | $4.28M | $3.07M | $1.39M | $2.20M | $4.29M | $5.17M | $3.23M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $6526.00 | $104803.00 | $2.18M | $2.07M | $4.33M | $666000.00 | $3.06M | $8.16M | $48.89M | $32.89M | $25.69M | $34.19M | $37.70M |
| Free cash flow | $17.25M | $60.91M | $-35.04M | $-52.90M | $-105.42M | $-20.16M | $-105.65M | $-63.65M | $-144.49M | $-51.41M | $-1.97M | $20.89M | $-11.20M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — |